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Abstract
Background: Partial deletion of chromosome 21q is a very rare chromosomal abnormality associated with highly
variable phenotypes, such as facial dysmorphic features, heart defects, seizures, psychomotor delay, and severe to
mild intellectual disability, depending on the location and size of deletions. So far, three broad deletion regions of
21q have been correlated with the clinical phenotype.
Results: We described the clinical and genetic features of three family members (father and two siblings) and other
two unrelated patients with very wide range in age of diagnosis. All of them showed intellectual disability with very
variable symptoms, from mild to severe, and carried 21q interstitial deletions with different sizes and position, as
detected by conventional karyotype and array-CGH.
Conclusions: Our study provided additional cases of partial 21q deletions, allowing to better delineate the genotype-
phenotype correlations. In contrast to previous observations, we showed that deletions of the 21q proximal region are
not necessarily associated with severe phenotypes and, therefore, that mild phenotypes are not exclusively related to
distal deletions. To the best of our knowledge, this is the first report showing 21q deletions in adult patients associated
with mild phenotypes, mainly consisting of neurobehavioral abnormalities, such as obsessive-compulsive disorders,
poor social interactions and vulnerability to psychosis.
Keywords: Array Comparative Genomic Hybridization (array-CGH), Behavioral disorders, BTG3 (BTG family, Member 3),
DNA Copy Number Variations (CNVs), GRIK1 (glutamate receptor, Ionotropic, Kainate 1), Intellectual Disability (ID), Partial
21q monosomy, RBM11 (RNA binding motif protein 11)
Background
Partial deletion of chromosome 21q (ORPHA574) is a
very rare condition (<1/1,000,000) associated with highly
variable phenotypes, which include facial dysmorphic
features, heart defects, seizures, psychomotor delay, and
severe to mild intellectual disability, depending on the
size and position of the deletion [1].
In one of the most complete studies to date, Lyle et al.
[2] reported 11 cases of partial monosomy 21 and
outlined three deletion regions with the associated pheno-
typic severity ranging from mild to severe to lethal. Dele-
tions in the first region, ranging from the centromere to
approximately 31.2 Mb (21q21.3), are associated with a se-
vere phenotype. Deletions in the second region (31.2–
36 Mb), corresponding to the 21q22.11 band with a higher
gene density, produce a severe phenotype not compatible
with survival. On the other hand, deletions in the third re-
gion, from 36 to 37.5 Mb to the telomere (21q22.12-qter,
approximately 10 Mb), result in a relatively mild pheno-
type. However, other studies reported patients with prox-
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In this study, we investigated five patients from three un-
related Italian families with deletions of chromosome 21q
by conventional and molecular karyotyping (array-CGH),
in order to underline new insights on genotype-phenotype
correlations. In addition, previously published cases with
chromosome 21q monosomies and similar deletions have
been reviewed. Altogether, our data provide a further dis-




Patient 1 was a 53 years old male, father of cases 2 and 3.
The patient was born full-term. He achieved the middle
school graduation and then experienced different jobs (gar-
dener, bricklayer, crane worker), being frequently fired after
short periods. His mother (79 years old) was affected by
hypertension and the father (80 years old) by insulin
dependent diabetes mellitus and stroke. The patient had a
55 years old brother who was also affected by diabetes. He
was first evaluated at the age of 53 years, after that chromo-
some 21 deletion had been ascertained in his children.
The clinical evaluation documented mild facial dys-
morphisms, such as deep set eyes, large ears and promin-
ent nose (Fig. 1a). The neurological evaluation revealed
mild head tremor and postural hand tremor. The Nuclear
Magnetic Resonance (NMR) documented a periventricu-
lar white matter hyperintensity and enlarged cisterna
magna. The electromyography (EMG) showed bilateral
entrapment of median nerve at the wrist. The patient was
scarcely collaborating and quite anxious. He frequently
showed the tendency to give a very positive image of him-
self. The language was rather simple. The evaluation by
DSM-IV (Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition) documented a psychotic dis-
order with persecutory delusion. High levels of aggressive-
ness and impairment in behavioural control were well
documented as well as alcohol abuse. Total IQ was 87,
without any important discrepancy among verbal subtests
(Verbal IQ = 88,) and the performance ones (Performance
IQ = 88). Poor attentive skills, short-term memory and
limited funds of knowledge acquired through school and
cultural experience were documented by verbal subtests.
Abstract thinking and understanding were very simple,
with limited ability to synthesize verbal relationships and
Fig. 1 Clinical features (a), G-banded karyotypes (b) and array-CGH profiles (c) of patients with chromosome 21q deletions. Chromosomes 21
shown in the red boxes (b) are enlarged in respect to the original karyograms. Parents of patient 4 denied permission to publish pictures
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social knowledge. The computational skills were also very
limited, as well as the logical-deductive and abstract
reasoning.
Patient 2
Patient 2 was the oldest child of patient 1. He was born at
term by caesarean section (weight 2,900 g). He started
walking at 18 months and pronounced the first compre-
hensible words at 14 months. He attended 3 years of pre-
school and started the primary school at 7 years. Then he
attended a professional school care for mentally-disabled
people. He was first evaluated at the age of 20 years be-
cause of mild intellectual disability, requiring a dedicated
teacher at school, and autistic-like features.
The clinical examination revealed a coarse facies with
nuchal low set hair, frontal alopecia, prominent fore-
head, small palpebral fissures, prominent nose, prog-
nathism and large ears (Fig. 1a). The neurological
evaluation revealed mild postural hand tremor and al-
tered saccadic eye movements. The Magnetic Resonance
Imaging (MRI), performed at the age of 18 years,
showed mild periventricular white matter hyperintensity
and enlarged cisterna magna. The EMG revealed mild
sensorimotor axonal neuropathy and autonomic dys-
function. During examination, the patient showed ad-
equate levels of attention and concentration. The
evaluation by DSM-IV criteria for ID diagnosis docu-
mented the presence of a compulsive-obsessive disorder.
The patient referred binge eating episodes, occurring
during the night, and compulsive smoking (60 ciga-
rettes/day). He was sufficiently autonomous and able to
work. His global IQ was 79 (borderline level), without
discrepancy among the verbal subtests (Verbal IQ = 79)
and the performance ones (Performance IQ = 82). He
demonstrated good comprehension skills, but low atti-
tudes in numerical reasoning and a poor vocabulary. Se-
lective and focused attention, mental control and
response flexibility, as assessed by the Stroop Test, re-
sulted inadequate.
Patient 3
Patient 3 was a 22 years old female, the younger child of
patient 1. She was born at term with caesarean section
(weight 2,600 g). She pronounced the first words at
18 months of age. She was first evaluated at the age of
18 years because of mild intellectual disability requiring
a dedicated teacher at school.
The clinical evaluation revealed coarse facies with nu-
chal low set hair, small palpebral fissures, prominent
nose, large ears and large flat mouth (Fig. 1a), as docu-
mented in cases 1 and 2. The neurological evaluation re-
vealed mild postural hand tremor and normal saccadic
eye movements. Visual and BAEP (Brainstem Auditory
Evoked Potentials) evoked potentials were normal. The
audiometric examination documented mild neurosen-
sory hypoacusia. The EMG showed no sign of peripheral
neuropathy and mild autonomic dysfunction. The MRI
showed mega cisterna magna. At the cognitive and be-
havioural assessment, the patient was generally collabor-
ating and cooperative. During the talks, she often
showed propensity to give fast and impulsive answers.
The evaluation by DSM-IV criteria revealed – as in pa-
tients 1 and 2 – the presence of impulsivity (compulsive
buying disorder). Cognitive evaluation documented a
borderline IQ of 78, with a light discrepancy among the
verbal subtests and the performance ones (Verbal IQ =
81; Performance IQ = 76). As documented in the
brother, she had good comprehension skills, but low atti-
tudes in numerical reasoning and poor vocabulary. In
addition, social insight, spatial perception, problem solv-
ing, logical and sequential reasoning appeared limited.
Patient 4
Patient 4 was a 16 years old girl, daughter of two non-
consanguineous healthy parents. She was born at term
after uneventful pregnancy (birth weight: 3,400 g, birth
length: 50 cm). The mother had a spontaneous miscar-
riage during a previous pregnancy.
The clinical evaluation documented some dysmorphic
features, such as low hair line and widely spaced nipples.
In primary school she was noted to have learning diffi-
culties associated with dyslexia and dyscalculia. She was
diagnosed with a visual-praxis difficulty and a full-scale
IQ at the lower end of normal range (77), with signifi-
cant discrepancies between verbal (IQ = 100) and per-
formance (IQ = 59) scores. At the neuropsychological
evaluation the patient revealed low self-esteem, strong
insecurity and poor social adaptation skills. Major depres-
sive episodes, together with anxiety and distress, and be-
havioral disorganization were also well documented.
Written communication skills were deeply impaired due
to deficient visuospatial organization and global move-
ment impairment. She started gaining weight progressively
at the age of 6, and developed primary amenorrhoea at
the age of 15. She presented thelarche and pubarche at
the age of 13 and familial history of delayed puberty was
reported in the paternal pedigree. Although GnRH stimu-
lation test showed a pubertal response of LH and FSH
(LH peak of 12.7 mU/ml, FSH peak of 11 mU/ml), with a
concentration of oestradiol (E2) of 40 pg/ml (normal pu-
bertal values >15 pg/ml), FSH and LH peaks were lower
than the expected for age, according to functional imma-
turity of the hypothalamus-pituitary-gonadal axis. The
brain MRI showed normal signal of both anterior
and posterior pituitary gland, with a normal pituitary
stalk. The MRI with contrast highlighted the pres-
ence of a microadenoma (35 mm) at the centre of
the hypophysis.
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Patient 5
Patient 5 was a 6 years old boy, son of two non-
consanguineous healthy parents. His father suffered
from idiopathic focal epilepsy of infancy and childhood,
and the mother was healthy. He was born at term after
an uneventful pregnancy (birth weight: 3,070 g, birth
length: 50 cm). The proband also had a heterozygotic
twin brother with normal neurological assessment, nor-
mal IQ score (88), and obesity.
A mild psychomotor delay was reported since the pro-
band was only 5 months old. A delay of the expressive
language was revealed at 2 years of life, with speech very
poor and simple. Personal autonomy skills (e.g. toilet
training, routine clothing, and use of cutlery) were also
deeply impaired. At the present age the patient had bi-
lateral iris and choroidal coloboma, Duane syndrome
type 3 of the left eye (Fig. 1a), hypotonia of both arms
and legs, and developmental coordination disorder
(DCD), as confirmed by the Movement Assessment Bat-
tery for Children (MABC), with a score below the 5th
percentile. The patient presented a borderline IQ [total
IQ = 74, without discrepancy between verbal (IQ = 80)
and performance (IQ = 82) scores] and required the sup-
port of a dedicated teacher. He also lacked proactivity in
the relationship game and in accessing language expres-
sion, characterized by simple speech with a reduced vo-
cabulary. The instrumental examination by Nuclear
Magnetic Resonance (NMR) revealed hypoplasia of cor-
pus callosum, inferior vermis and pons, as well as bilat-
eral anomalies of the course of the sixth cranial nerve.
Conventional and molecular karyotyping
In the three affected family members (patients 1–3), the
karyotyping and the array-CGH analysis revealed a
chromosome 21q interstitial deletion of approximately
10.6 Mb (chr21:21,754,822-32,380,347, hg38), and ex-
cluded the presence of any other genomic imbalance
(Table 1, Fig. 1b and c). In patient 4, both karyotype and
array-CGH detected a larger deletion, spanning approxi-
mately 14.5 Mb (chr21:13,048,294-27,532,614, hg38;
Table 1, Fig. 1b and c). No other significant chromo-
somal rearrangements were revealed in the proband and
the parental GTG-banded karyotypes showed a normal
chromosomal asset. In case 5, the array-CGH demon-
strated two genomic rearrangements: arr[hg38]
21q11.2q21.3 (14,000,146-27,785,985)x1 (Table 1, Fig. 1b
and c), and the typical 220-kb deletion on chromosome
16p11.2 (OMIM 613444), arr[hg38] 16p11.2 (28,813,473-
29,030,738)x1. The parental GTG-banded karyotypes
were normal and the array-CGH analysis confirmed that
the large 21q deletion appeared de novo in their child.
On the contrary, the rearrangement on chromosome 16
was also detected in the mother and the proband’s het-
erozygotic twin. The molecular and clinical details of
our cases have been referenced in the ClinVar database
(http://www.ncbi.nlm.nih.gov/clinvar): Patients 1–3
(#SCV000239859), Patient 4 (#SCV000239860), Patient
5 (#SCV000239861).
Discussion
Partial deletions of chromosome 21q are commonly as-
sociated with highly heterogeneous phenotypes. In this
study we characterized five patients with partial 21q
monosomies by array-CGH and conventional karyotyp-
ing. The three family members (patients 1–3) showed
mild clinical features, such as facial dysmorphisms and
behavioral abnormalities, mainly consisting of obsessive-
compulsive features, poor social interactions and vulner-
ability to psychosis, fully expressed in the father. High
levels of impulsivity, repeatedly identified as a major
problem in schizophrenia, were present in all the family
members: alcohol abuse (father), compulsive smoking
(son) and shopping/spending addiction (daughter). The
phenotypic intrafamilial variability might be due to addi-
tive genetic and environmental factors that potentially
have accumulated in the oldest member of the family. A
deletion comprising 21q21.2 and the proximal segment
of 21q22.1 has been previously associated with schizo-
phrenia susceptibility [6], although a recent multi-stage
genome-wide association study failed to detect
schizophrenia-associated genetic locus on chromosome
21 [7]. Interestingly, all family members presented pos-
tural hand tremor, a symptom never described in associ-
ation with chromosome 21q deletions. In agreement
with our observations, it has been reported that Sod1−/−
mice presented tremors along with gait disturbances and
skeletal muscle atrophy [8, 9]. However, according to
Decipher, no cases of SOD-1 deletions (chr21:31659622–
31668930, hg38) have been associated with tremor until
now and the unique family with SOD-1 null mutation
manifested an atypical form of familial amyotrophic lat-
eral sclerosis [10].
Compared to patients 4 and 5, the three family mem-
bers carried the deletion of GRIK1 mapping to the
21q21.3 region (Fig. 2). This gene (OMIM 138245)
might be considered a plausible candidate for autism
and other neurobehavioral disorders, since it codifies for
a protein belonging to the kainate family of excitatory
glutamate receptors that are activated in a variety of
neurophysiologic processes. Moreover, GRIK1 alterations
were shown to be associated with various neurobehav-
ioral phenotypes in humans, such as anxiety disorders,
schizophrenia, bipolar disorder, epilepsy and PDD-NOS
(pervasive developmental disorder not otherwise speci-
fied) [11–13], as well as with anxiety-like behaviors in
GRIK1 knockout mice – due to its regulation of inhibi-
tory circuits in the amygdala [14]. Accordingly, the be-
havioral disorders observed in our family suggest that
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Table 1 Summary of patients harboring 21q deletions overlapping with patients 1–5 and corresponding clinical features
Patient Age at
diagnosis (yr)







53 (#1), 20 (#2), 18 (#3) Obsessive-compulsive disorders, impaired social
interactions, aggressiveness, delayed speech and
language development, mild facial dismorphisms
chr21:21754822-32380347 10.63 112 (52) Paternal Pathogenic
Patient 4
(present study)
6 Intellectual disability, global movement impairment,
dysmorphic features, dyslexia, dyscalculia, primary
amenorrhoea, obesity, pituitary microadenoma
chr21:13048294-27532614 14.48 117 (21) De novo Pathogenic
Patient 5
(present study)
4 Intellectual disability, mild psychomotor delay, speech
delay, hypotonia, DCD (a), Duane syndrome type 3,
bilateral iris/choroidal coloboma
chr21:14000146-27785985 13.79 112 (23) De novo Pathogenic
chr16:28813473-29030738 0.22 35 (24) Maternal Pathogenic
Case 1 (Petit et al.,
2015) [24]
Decipher#276325
7 Behavioural/psychiatric abnormality, attention deficit,
impaired social interactions, frustration, aggressiveness,
delayed speech and language development
chr21:21062316-24943120 3.88 16 (1) Maternal Unknown
Case 2 (Petit et al.,
2015) [24]
Decipher#254181
9 Global developmental delay, speech delay, hyperactivity,
impairment of social interactions
chr21:15619936-23525918 7.91 50 (9) Paternal
(mosaicism)
Unknown
Case 3 (Petit et al.,
2015) [24]
Decipher#274603
5 Global developmental delay, hypotonia, constipation,
impaired social interactions
chr21:16079383-24575840 8.50 48 (7) Unknown Unknown




6 Speech delay, mild/moderate mental retardation,
dysmorfic features, hypotonia, GERD (b), eczema,
dermatographism
chr21:16814345-33232252 16.42 159 (69) De novo Unknown
chr4:65863868-66006319 0.14 0 Maternal Unlikely
pathogenic
chr14:22625231–22795061 (c) 0.17 (c) 2 (2) Paternal Unlikely
pathogenic
GM00137 - cohort B
(Roberson et al.,
2011) [1]
6 Severe psychomotor retardation, microcephaly,
dysmorphic features, bilateral iris coloboma
chr21:13403408-28392024 14.99 124 (23) Unknown Unknown
chr4:68917-11238519 11.17 229 (122) Unknown Unknown
GM06918 - cohort
B (Roberson et al.,
2011) [1]
9 Mental retardation, dysmorphic features chr21:14981488-32298829 17.32 156 (61) De novo Unknown
Haldeman-Englert
et al., 2010 [13]
2 Poor social interactions, speech delay, mild
dysmorphic features, PDD-NOS (d)
chr21:21085454-29813876 8.73 62 (18) De novo Pathogenic
Case 31 (Lyle et al.,
2009) [2]
Unknown Dysmorphic features, short stature, mental
retardation, synbrachydactily
chr21:12965809-30890916 17.93 180 (56) Unknown Unknown
Case 32 (Lyle et al.,
2009) [2]
Unknown Dysmorphic features, short stature, mental
retardation, microcephaly, clinodactily, hypotonia
chr21:12965809-30218169 17.26 145 (31) Unknown Unknown
Case 33 (Lyle et al.,
2009) [2]
Unknown Mental retardation chr21:12965809-26199556 13.23 108 (15) Unknown Unknown
Hannachi et al.,
2011 [20]
26 Moderate mental retardation, minor brain
malformations, craniofacial dysmorphic
features, azoospermia, diffuse cerebral atrophy












Table 1 Summary of patients harboring 21q deletions overlapping with patients 1–5 and corresponding clinical features (Continued)
Decipher#285024 2 Ataxia, intellectual disability, poor speech, lower
limb spasticity, speech articulation difficulties
chr21:13224687-27912651 14.69 124 (23) Unknown Pathogenic
Decipher#285691 10 Cognitive impairment, generalized myoclonic
seizures, microcephaly, asymmetry of the ears
chr21:13045202-33522318 20.48 217 (76) Unknown Pathogenic
ECARUCA#4777 16 Mental retardation, seizures/abnormal EEG (e),
short stature, prominent maxilla, dislocation
of hip, atrial septum defect
chr21:14166659-20412272 6.25 66 (13) De novo Unknown
chr21:43013575-46699983 3.69 116 (67) De novo Unknown
ECARUCA#4841 9 Mental retardation, seizures/abnormal EEG (e),
facial dysmorphisms
chr21:15292766-19704615 4.41 31 (6) De novo Unknown











GRIK1 might be considered the most favorable candi-
date gene.
Patients 4 and 5, with similar proximal 21q deletions,
showed the most severe clinical features, mainly consist-
ing in intellectual disability (Table 1). Moreover, case 5
also harbored an additional deletion at 16p11.2, inher-
ited from the clinically normal mother. Since this dele-
tion has been previously linked to developmental delay,
autism spectrum disorder and epilepsy [15–17], its
additive effect on our patient’s phenotype might also be
considered. In addition, the 220-kb 16p11.2 deletion has
also been widely associated with susceptibility to isolated
severe early-onset obesity (OMIM 613444) [18]. Interest-
ingly, the proband and his mother were normal weight,
whereas the proband’s heterozygotic twin harboring the
same deletion was obese, thus supporting the incomplete
penetrance and the clinical variability of this chromo-
somal alteration [19].
Fig. 2 Comparison of 21q deletion cases with mild (purple) and moderate/severe (green) phenotypes (behavioral disorders and intellectual disability,
respectively). The protein-coding genes of 21q region are mainly grouped into two main clusters. The proximal cluster includes genes
more likely involved in intellectual disability (BTG3 and RBM11), whereas the distal cluster mainly contains genes related to behavioral disorders, such as
GRIK1 (almost completely deleted in the case reported by Haldeman-Englert et al., [13]). KKI-3, GM00137, and ECARUCA#4777 cases also
had rearrangements involving chromosomes other than 21 (as reported in Table 1) that might contribute to the clinical severity
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The findings that patients 4 and 5 presented more se-
vere clinical features than patients 1–3 are in agreement
with previously reported cases (Table 1 and Fig. 2) [1, 2,
20], where the proximal 21q deletions encompassed two
genes expressed in the central nervous system, RBM11
(21q11.2) and BTG3 (21q21.1), that might play a role in
intellectual disability. RBM11 was deleted in 10 out of
15 cases with the most severe phenotype (intellectual
disability), whereas BTG3 in all of these cases (Fig. 2).
RBM11 is a tissue-specific splicing factor that mediates
the alternative splicing process during neuronal differen-
tiation [21]. BTG3 (OMIM 605674) is involved in the
neurogenesis of the developing central nervous system,
where it acts as a regulator of cell proliferation and
apoptosis [22]. Deletions of BTG3 have been reported in
a subset of patients with autism characterized by develop-
mental regression [23] and in patients with neurodevelop-
mental delay [24] (Decipher 285691, 285987, 288573,
291626, and 300775). Moreover, BTG3 deletions have also
been associated with delayed speech (Decipher 249224,
277597, and 285024), as observed in our patient 5.
Conclusions
Although further investigations of other cases are
needed, our preliminary results provide new insights on
the traditional model firstly proposed by Lyle and col-
leagues in 2009 [2], making it possible to tentatively sub-
set their original great region 1 (21qcen-21q21.3) into
two smaller subregions. Deletions in the subregion 1,
spanning from the centromere to approximately 21 Mb
(21q21.1), are mainly associated with intellectual disabil-
ity, whereas deletions of subregion 2, until approxi-
mately 32 Mb (21q22.11), are more tightly associated
with neurobehavioral disorders, such as obsessive-
compulsive disorders, poor social interactions and vul-
nerability to psychosis (Fig. 3). Interestingly, the sub-
region 2 also includes a portion of the 21q22.11 band,
whose deletion was traditionally considered associated
with severe and even lethal phenotypes. This finding
may be due to the fact that most of the disease-related
genes, such as SYNJ1, ITSN1, SLC5A3/SMIT1 and
KCNE2 [25–29], are clustered in the distal part of the
band with the highest gene density.
According to the literature, very few cases of behav-
ioral disorders with 21q deletions have been described
until now [13, 24]. Indeed, attenuated phenotypes, such
as poor social interactions, may be easily neglected and
further genetic analyses are undertaken only when a sug-
gestive familiar history is clearly ascertained. The spread-
ing of genetic tests along with increasing evidences that
copy number variations are linked to complex neuro-
psychiatric disorders [30, 31] will certainly unveil new
cases in the near future.
Methods
Conventional karyotyping
Phytohaemagglutinin (PHA)-stimulated lymphocyte cul-
tures were set up from peripheral blood samples and the
chromosomal analysis was carried out on GTG banded
metaphases, according to standard procedures.
Molecular karyotyping
Molecular karyotyping (array-CGH) was performed on
DNA samples, extracted from patient’s peripheral blood
according to standard methods, by using a whole-
genome 180 K Agilent array (Human Genome CGH
Microarray, Agilent Technologies, Santa Clara, CA,
USA), according to manufacturer’s protocol. Data were
analyzed by using the Agilent Genomic Workbench
Standard Edition 6.5.0.58. All genomic positions were re-
ported according to the latest human genome assembly
(GRCh38/hg38).
Fig. 3 Subsetting of the great 21q region 1 described by Lyle and colleagues in 2009 into two smaller subregions. Deletions in the subregion 1,
from the centromere to ~ 21 Mb (including BTG3 and RBM11), are mainly associated with severe intellectual disability, whereas deletions of the
subregion 2, until approximately 32 Mb (including GRIK1), are more tightly associated with milder neurobehavioral disorders, such as poor social
interactions. Patients with a deletion overpassing the two subregions clinically manifested the most severe phenotype
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